116 related articles for article (PubMed ID: 18516755)
1. Immunotherapy of pancreatic carcinoma.
Märten A; Büchler MW
Curr Opin Investig Drugs; 2008 Jun; 9(6):565-9. PubMed ID: 18516755
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of pancreatic carcinoma.
Märten A
Rev Recent Clin Trials; 2008 May; 3(2):121-5. PubMed ID: 18474022
[TBL] [Abstract][Full Text] [Related]
3. Research trends in the treatment of neoplasms of the exocrine pancreas.
Cellini N; Morganti AG; Luzi S; Macchia G; Smaniotto D; Trodella L
Rays; 2000; 25(3):375-7. PubMed ID: 11367905
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trials in pancreatic adenocarcinoma.
Rudloff U; Maker AV; Brennan MF; Allen PJ
Surg Oncol Clin N Am; 2010 Jan; 19(1):115-50. PubMed ID: 19914563
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
6. Medical management of pancreatic neuroendocrine tumors.
Delaunoit T; Neczyporenko F; Rubin J; Erlichman C; Hobday TJ
Am J Gastroenterol; 2008 Feb; 103(2):475-83; quiz 484. PubMed ID: 18028508
[TBL] [Abstract][Full Text] [Related]
7. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer.
Tamm I
Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
9. GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers.
Nava-Parada P; Emens LA
Curr Opin Mol Ther; 2007 Oct; 9(5):490-7. PubMed ID: 17932813
[TBL] [Abstract][Full Text] [Related]
10. Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.
Coveler AL; Rossi GR; Vahanian NN; Link C; Chiorean EG
Immunotherapy; 2016 Feb; 8(2):117-25. PubMed ID: 26787078
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
12. Molecular therapy in pancreatic adenocarcinoma.
MacKenzie MJ
Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy combined with chemotherapy in the treatment of tumors.
Frazier JL; Han JE; Lim M; Olivi A
Neurosurg Clin N Am; 2010 Jan; 21(1):187-94. PubMed ID: 19944977
[TBL] [Abstract][Full Text] [Related]
14. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
15. Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.
Rouanet M; Lebrin M; Gross F; Bournet B; Cordelier P; Buscail L
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594388
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress.
Wolff RA; Varadhachary GR; Evans DB
Ann Surg Oncol; 2008 Oct; 15(10):2773-86. PubMed ID: 18612703
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of the pancreas. A program for increasing survival.
Humphrey LJ; Hartman GV
J Kans Med Soc; 1974 Sep; 75(9):281-2. PubMed ID: 4137564
[No Abstract] [Full Text] [Related]
20. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
